HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nirmal K Banda Selected Research

Complement 3d Receptors (Complement Receptor 2)

1/2013Human complement receptor 2 (CR2/CD21) as a receptor for DNA: implications for its roles in the immune response and the pathogenesis of systemic lupus erythematosus (SLE).
11/2009Targeted inhibition of the complement alternative pathway with complement receptor 2 and factor H attenuates collagen antibody-induced arthritis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nirmal K Banda Research Topics

Disease

24Arthritis (Polyarthritis)
01/2022 - 08/2006
12Rheumatoid Arthritis
01/2022 - 04/2011
11Inflammation (Inflammations)
11/2021 - 08/2006
8Experimental Arthritis
12/2020 - 11/2002
2Thrombosis (Thrombus)
11/2021 - 01/2012
2Neoplasms (Cancer)
01/2020 - 11/2015
2Joint Diseases (Joint Disease)
06/2015 - 06/2013
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
11/2014 - 01/2013
1Kyphosis
12/2021
1Axial Spondyloarthritis
12/2021
1Necrosis
11/2021
1Cardiovascular Diseases (Cardiovascular Disease)
11/2021
1Choroidal Neovascularization
12/2020
1Retinal Degeneration
12/2020
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2018
1Lung Injury
01/2018
1Autoimmune Diseases (Autoimmune Disease)
11/2014
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
11/2014
1Diabetes Mellitus
11/2014
1Complement Component 6 Deficiency
02/2012
1Osteoarthritis
11/2011
1Vascular Diseases (Vascular Disease)
08/2011

Drug/Important Bio-Agent (IBA)

24Complement System Proteins (Complement)IBA
01/2022 - 11/2002
21CollagenIBA
12/2021 - 08/2006
10Proteins (Proteins, Gene)FDA Link
01/2020 - 08/2003
6Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
09/2018 - 11/2010
5Messenger RNA (mRNA)IBA
01/2022 - 08/2006
5Complement Inactivating AgentsIBA
01/2020 - 08/2003
5LectinsIBA
01/2020 - 08/2006
5Mannose-Binding Protein-Associated Serine Proteases (Mannose-Binding Protein-Associated Serine Protease)IBA
01/2017 - 11/2010
4Complement Factor H (Factor H)IBA
11/2021 - 11/2009
3AntibodiesIBA
01/2020 - 01/2009
3Complement Receptors (Complement Receptor)IBA
01/2020 - 08/2003
3Serine (L-Serine)FDA Link
09/2018 - 01/2012
3Antigen-Antibody Complex (Immune Complex)IBA
06/2013 - 09/2007
2Collectins (Collectin)IBA
01/2021 - 01/2017
2CytokinesIBA
01/2021 - 01/2009
2Complement Factor D (Factor D)IBA
01/2020 - 11/2016
2ferric oxide (iron oxide)IBA
01/2020 - 11/2015
2Collagen Type II (Type II Collagen)IBA
01/2018 - 08/2006
2AutoantibodiesIBA
01/2018 - 04/2011
2Serine Proteases (Serine Protease)IBA
11/2016 - 11/2010
2Complement 3d Receptors (Complement Receptor 2)IBA
01/2013 - 11/2009
1NeopterinIBA
11/2021
1ApolipoproteinsIBA
11/2021
1LipidsIBA
11/2021
1C-Reactive ProteinIBA
11/2021
1Serum Amyloid A Protein (Serum Amyloid A)IBA
11/2021
1factor H-related protein 1IBA
11/2021
1Immunoglobulin G (IgG)IBA
01/2021
1sodium iodateIBA
12/2020
1AcetylgalactosamineIBA
01/2020
1lepirudin (Refludan)FDA Link
01/2020
1compstatinIBA
01/2020
1Epithelial Cell Adhesion MoleculeIBA
01/2020
1Immunoglobulin M (IgM)IBA
01/2020
1Phospholipids (Phosphatides)FDA LinkGeneric
01/2020
1EpitopesIBA
01/2019
1Combined Antibody TherapeuticsIBA
01/2019
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2018
1Complement C3 (C3 Complement)IBA
01/2018
1indium-bleomycinIBA
01/2018
1LigandsIBA
01/2017
1EnzymesIBA
01/2017
1Edetic Acid (EDTA)FDA Link
11/2015
1Dextrans (Dextran)FDA Link
11/2015
1Small Interfering RNA (siRNA)IBA
06/2015
1Protein CIBA
11/2014
1Dichlorodiphenyldichloroethane (DDD)IBA
11/2014
1Antinuclear AntibodiesIBA
01/2013
1DNA (Deoxyribonucleic Acid)IBA
01/2013
1Anaphylatoxin C5a ReceptorIBA
02/2012
1Complement C5 (Complement 5)IBA
11/2011
1Complement Membrane Attack Complex (Membrane Attack Complex)IBA
11/2011
1AmidesIBA
04/2011
1Protein-Arginine DeiminasesIBA
04/2011
1N- alpha- benzoyl- N5- (2- chloro- 1- iminoethyl)- L- ornithine amideIBA
04/2011
1amsonic acid (DAS)IBA
11/2009
1Therapeutic UsesIBA
01/2009
1AdiponectinIBA
01/2009
1beta-Galactosidase (Lactaid)IBA
01/2009
1Complement Factor B (Factor B)IBA
09/2007
1Mannose-Binding LectinsIBA
09/2007
1Superoxide DismutaseIBA
11/2004
1Superoxides (Superoxide)IBA
11/2004
1Complement C3-C5 Convertases (C3 Convertase)IBA
08/2003
1Carrier Proteins (Binding Protein)IBA
02/2003
1Interleukin-18 (Interleukin 18)IBA
02/2003

Therapy/Procedure

2Lasers (Laser)
12/2020 - 06/2013
1Therapeutics
01/2020